Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hemenway, Jeffrey N."'
Autor:
Hemenway, Jeffrey N. *, Carvalho, Thiago C., Rao, Venkatramana M., Wu, Yongmei, Levons, Jaquan K., Narang, Ajit S., Paruchuri, Srinivasa R., Stamato, Howard J., Varia, Sailesh A.
Publikováno v:
In Journal of Pharmaceutical Sciences September 2012 101(9):3305-3318
Autor:
Hemenway, Jeffrey N., Stella, Valentino J. *
Publikováno v:
In Journal of Pharmaceutical Sciences November 2010 99(11):4565-4575
Autor:
Hemenway, Jeffrey N., Jarho, Pekka, Henri, John T., Nair, Sajiv K., VanderVelde, David, Georg, Gunda I., Stella, Valentino J. *
Publikováno v:
In Journal of Pharmaceutical Sciences April 2010 99(4):1810-1825
Autor:
Jim Zheng, Matthew Robert Warr, Bill J. Smith, Lisa Moorehead, Bernard P. Murray, Jeffrey A. Silverman, John Ling, Raju Subramanian, Jingyu Zhang, Yan Xin, Ellen Kwan, J. Andrew Whitney, Hemenway Jeffrey N
Publikováno v:
Drug Metabolism and Disposition. 46:237-247
Momelotinib (MMB), a small-molecule inhibitor of Janus kinase (JAK)1/2 and of activin A receptor type 1 (ACVR1), is in clinical development for the treatment of myeloproliferative neoplasms. The pharmacokinetics and disposition of [14C]MMB were chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6ca91bf722b61fe9a2e7b79eeb79385
https://doi.org/10.1124/dmd.117.078899
https://doi.org/10.1124/dmd.117.078899
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dimitrios Stefanidis, Julie Maltzman, Hemenway Jeffrey N, Yan Xin, Wei Deng, Jeffrey A. Silverman, Lixin Shao, Thomas Tarnowski
Publikováno v:
Clinical pharmacology in drug development. 7(3)
Momelotinib is a potent and selective small-molecule inhibitor of JAK1/2 that is under investigation for the treatment of myeloproliferative neoplasms. In a phase 1/2 study in myelofibrosis patients, once-daily dosing of a 300-mg momelotinib capsule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4206fc2a65312b5cf74d1a169244827
https://pubmed.ncbi.nlm.nih.gov/29024542
https://pubmed.ncbi.nlm.nih.gov/29024542
Autor:
Hemenway, Jeffrey N., Carvalho, Thiago C., Mantri, Rao V., Wu, Yongmei, Levons, Jaquan K., Narang, Ajit S., Paruchuri, Srinivasa R., Stamato, Howard J., Varia, Sailesh A.
Publikováno v:
Excipient Applications in Formulation Design & Drug Delivery; 2015, p67-91, 25p
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 2007 17(23):6629-6632
Publikováno v:
Chirality; 2000, Vol. 12 Issue 9, p688-696, 9p